Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John C. Mullen is active.

Publication


Featured researches published by John C. Mullen.


Obesity | 2008

Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis.

Antigone Oreopoulos; Raj Padwal; Colleen M. Norris; John C. Mullen; Victor Pretorius; Kamyar Kalantar-Zadeh

Objective: Overweight and obesity are often assumed to be risk factors for postprocedural mortality in patients with coronary artery disease (CAD). However, recent studies have described an “obesity paradox”—a neutral or beneficial association between obesity and mortality postcoronary revascularization. We reviewed the effect of overweight and obesity systematically on short‐ and long‐term all‐cause mortality post‐coronary artery bypass grafting (CABG) and post‐percutaneous coronary intervention (PCI).


The New England Journal of Medicine | 2015

Surgical ablation of atrial fibrillation during mitral-valve surgery

A. Marc Gillinov; Annetine C. Gelijns; Michael K. Parides; Joseph J. DeRose; Alan J. Moskowitz; Pierre Voisine; Gorav Ailawadi; Denis Bouchard; Peter K. Smith; Michael J. Mack; Michael A. Acker; John C. Mullen; Eric A. Rose; Helena L. Chang; John D. Puskas; Jean-Philippe Couderc; Timothy J. Gardner; Robin Varghese; Keith A. Horvath; Steven F. Bolling; Robert E. Michler; Nancy L. Geller; Deborah D. Ascheim; Marissa A. Miller; Emilia Bagiella; Ellen Moquete; Paula Williams; Wendy C. Taddei-Peters; Patrick T. O'Gara; Eugene H. Blackstone

BACKGROUND Among patients undergoing mitral-valve surgery, 30 to 50% present with atrial fibrillation, which is associated with reduced survival and increased risk of stroke. Surgical ablation of atrial fibrillation has been widely adopted, but evidence regarding its safety and effectiveness is limited. METHODS We randomly assigned 260 patients with persistent or long-standing persistent atrial fibrillation who required mitral-valve surgery to undergo either surgical ablation (ablation group) or no ablation (control group) during the mitral-valve operation. Patients in the ablation group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure. All patients underwent closure of the left atrial appendage. The primary end point was freedom from atrial fibrillation at both 6 months and 12 months (as assessed by means of 3-day Holter monitoring). RESULTS More patients in the ablation group than in the control group were free from atrial fibrillation at both 6 and 12 months (63.2% vs. 29.4%, P<0.001). There was no significant difference in the rate of freedom from atrial fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the biatrial maze procedure (61.0% and 66.0%, respectively; P=0.60). One-year mortality was 6.8% in the ablation group and 8.7% in the control group (hazard ratio with ablation, 0.76; 95% confidence interval, 0.32 to 1.84; P=0.55). Ablation was associated with more implantations of a permanent pacemaker than was no ablation (21.5 vs. 8.1 per 100 patient-years, P=0.01). There were no significant between-group differences in major cardiac or cerebrovascular adverse events, overall serious adverse events, or hospital readmissions. CONCLUSIONS The addition of atrial fibrillation ablation to mitral-valve surgery significantly increased the rate of freedom from atrial fibrillation at 1 year among patients with persistent or long-standing persistent atrial fibrillation, but the risk of implantation of a permanent pacemaker was also increased. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00903370.).


The Annals of Thoracic Surgery | 1995

Right atrial lipoma

John C. Mullen; Shirley A. Schipper; Suvro S. Sett; George A. Trusler

The case of a patient undergoing successful surgical resection of a huge lipoma of the right atrium is presented. The diagnosis was established preoperatively by magnetic resonance imaging. The tumor was involved intimately with the right coronary artery, and careful identification and dissection were required to preserve the vessel. The tumor was removed successfully, and follow-up at 1 year showed no evidence of recurrence.


The Annals of Thoracic Surgery | 1998

Biatrial myxoma: a rare cardiac tumor.

John L Peachell; John C. Mullen; Michael J Bentley; Dylan Taylor

A previously healthy 48-year-old man presented to the hospital with a transient ischemic attack. Echocardiography revealed a large left atrial tumor with a second tumor in the right atrium. Surgical excision revealed a large left atrial myxoma with extension through the interatrial septum into the right atrium.


The Annals of Thoracic Surgery | 2001

Successful cardiac transplantation with methanol or carbon monoxide-poisoned donors.

Michael J Bentley; John C. Mullen; Steven R Lopushinsky; Dennis L. Modry

BACKGROUND Patients succumbing to methanol or carbon monoxide poisoning are usually rejected for heart donation. Increasing demand for donors has lead to the expansion of acceptance criteria and increased use of the marginal donor. METHODS We transplanted hearts from donors who had had methanol intoxication in three cases and carbon monoxide exposure in two cases. Standard donor evaluation criteria and transplantation techniques were used. RESULTS All of the transplants were successful. Three of the recipients required significant inotropic support for a few days postoperatively; however, all of the hearts functioned well over the intermediate and long term. Two recipients (1 from each group) died of complications other than heart failure (1.5 and 2 years postoperatively). CONCLUSIONS Successful heart transplantation can be achieved using the hearts from patients succumbing to methanol or carbon monoxide poisoning. Routine evaluation of cardiac function and myocardial damage is adequate for screening these donors. Hearts from methanol-poisoning victims may require longer inotropic support postoperatively before complete recovery, but can provide excellent long-term function and results.


The Annals of Thoracic Surgery | 1996

Recurrent Aortic Dissection After Orthotopic Heart Transplantation

John C. Mullen; Gillian Lemermeyer; Michael J Bentley

A patient with Marfans syndrome and previous Bentall repair for aortic dissection required orthotopic cardiac transplantation for end-stage cardiomyopathy. Postoperatively he suffered recurrent aortic dissection involving the transverse and descending aorta leading to tracheal and esophageal compression. He underwent successful surgical replacement of his ascending aorta, transverse arch, and descending aorta.


Urology | 1996

Metastatic testicular tumor requiring inferior vena cava resection

John C. Mullen; Gillian Lemermeyer; Jacques Tittley; E Michael Ameli; Alan G. Lossing; Michael A.S. Jewett

A patient undergoing radical retroperitoneal lymphadenectomy for metastatic embryonal cell testicular carcinoma is presented. Tumor resection required removal of the inferior vena cava due to transmural invasion. The inferior vena cava was replaced using externally stented polytetrafluoroethylene (PTFE) graft. Patency was documented by postoperative Doppler studies, duplex scanning, and computed tomographic scanning. Stented PTFE is currently the graft of choice for inferior vena caval replacement.


The Annals of Thoracic Surgery | 2001

Anomalous right coronary artery originating from the left main coronary artery

Steven R Lopushinsky; John C. Mullen; Michael J Bentley

A 54-year-old man with no cardiac history presented with exertional angina. Cardiac catheterization revealed an anomalous right coronary artery originating from the left main coronary artery with external compression during its course between the aorta and the pulmonary artery. He was successfully managed with surgical reimplantation of the right coronary artery into the aorta.


Circulation | 2016

Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.

Romain Capoulade; Xin Zeng; Jessica R. Overbey; Gorav Ailawadi; John H. Alexander; Deborah D. Ascheim; Michael E. Bowdish; Annetine C. Gelijns; Paul A. Grayburn; Irving L. Kron; Robert A. Levine; Michael J. Mack; Serguei Melnitchouk; Robert E. Michler; John C. Mullen; Patrick T. O’Gara; Michael K. Parides; Peter K. Smith; Pierre Voisine; Judy Hung

Background: In ischemic mitral regurgitation (IMR), ring annuloplasty is associated with a significant rate of recurrent MR. Ring size is based on intertrigonal distance without consideration of left ventricular (LV) size. However, LV size is an important determinant of mitral valve (MV) leaflet tethering before and after repair. We aimed to determine whether LV-MV ring mismatch (mismatch of LV size relative to ring size) is associated with recurrent MR in patients with IMR after restrictive ring annuloplasty. Methods: Patients with moderate or severe IMR from the 2 Cardiothoracic Surgical Trials Network IMR trials who received MV repair were examined at 1 year after surgery. Baseline LV size was assessed by LV end-diastolic dimension and LV end-systolic dimension (LVESd). LV-MV ring mismatch was calculated as the ratio of LV to ring size (LV end-diastolic dimension/ring size and LVESd/ring size). Results: At 1 year after ring annuloplasty, 45 of 214 patients with MV repair (21%) had moderate or greater MR. In univariable logistic regression analysis, larger LVESd (P=0.02) and LVESd/ring size (P=0.007) were associated with recurrent MR. In multivariable models adjusted for age, sex, baseline LV ejection fraction, and severe IMR, only LVESd/ring size (odd ratio per 0.5 increase, 2.20; 95% confidence interval, 1.05–4.62; P=0.038) remained significantly associated with 1-year MR recurrence. Conclusions: LV-MV ring size mismatch is associated with increased risk of MR recurrence. This finding may be helpful in guiding choice of ring size to prevent recurrent MR in patients undergoing MV repair and in identifying patients who may benefit from MV repair with additional subvalvular intervention or MV replacement rather than repair alone. Clinical Trial Registration: URL:http://clinicaltrials.gov. Unique identifiers: NCT00806988 and NCT00807040.


The Annals of Thoracic Surgery | 2017

A Prospective Multi-Institutional Cohort Study of Mediastinal Infections After Cardiac Operations

Louis P. Perrault; Katherine A. Kirkwood; Helena L. Chang; John C. Mullen; Brian C. Gulack; Michael Argenziano; Annetine C. Gelijns; Ravi K. Ghanta; Bryan A. Whitson; Deborah L. Williams; Nancy M. Sledz-Joyce; Brian Lima; Giampaolo Greco; Nishit Fumakia; Eric A. Rose; John D. Puskas; Eugene H. Blackstone; Richard D. Weisel; Michael E. Bowdish

BACKGROUND Mediastinal infections are a potentially devastating complication of cardiac operations. This study analyzed the frequency, risk factors, and perioperative outcomes of mediastinal infections after cardiac operations. METHODS In 2010, 5,158 patients enrolled in a prospective study evaluating infections after cardiac operations and their effect on readmissions and mortality for up to 65 days after the procedure. Clinical and demographic characteristics, operative variables, management practices, and outcomes were compared for patients with and without mediastinal infections, defined as deep sternal wound infection, myocarditis, pericarditis, or mediastinitis. RESULTS There were 43 mediastinal infections in 41 patients (cumulative incidence, 0.79%; 95% confidence interval [CI] 0.60% to 1.06%). Median time to infection was 20.0 days, with 65% of infections occurring after the index hospitalization discharge. Higher body mass index (hazard ratio [HR] 1.06; 95% CI, 1.01 to 1.10), higher creatinine (HR, 1.25; 95% CI, 1.13 to 1.38), peripheral vascular disease (HR, 2.47; 95% CI, 1.21 to 5.05), preoperative corticosteroid use (HR, 3.33; 95% CI, 1.27 to 8.76), and ventricular assist device or transplant surgery (HR, 5.81; 95% CI, 2.36 to 14.33) were associated with increased risk of mediastinal infection. Postoperative hyperglycemia (HR, 3.15; 95% CI, 1.32 to 7.51) was associated with increased risk of infection in nondiabetic patients. Additional length of stay attributable to mediastinal infection was 11.5 days (bootstrap 95% CI, 1.88 to 21.11). Readmission rates and mortality were five times higher in patients with mediastinal infection than in patients without mediastinal infection. CONCLUSIONS Mediastinal infection after a cardiac operation is associated with substantial increases in length of stay, readmissions, and death. Reducing these infections remains a high priority, and improving post-operative glycemic management may reduce their risk in patients without diabetes.

Collaboration


Dive into the John C. Mullen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Lien

University of Alberta

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Annetine C. Gelijns

Icahn School of Medicine at Mount Sinai

View shared research outputs
Top Co-Authors

Avatar

A. Kapasi

University of Alberta

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge